GF52166943
Samarium
foil, not light tested, 25x25mm, thickness 0.005mm, as rolled, 99%
Sign Into View Organizational & Contract Pricing
All Photos(2)
Samarium, SM000205
Sm
Assay
99%
form
foil
manufacturer/tradename
Goodfellow 521-669-43
resistivity
91.4 μΩ-cm, 0°C
size × thickness
25x25 mm × 0.005 mm
bp
1794 °C (lit.)
mp
1074 °C (lit.)
density
7.47 g/mL at 25 °C (lit.)
SMILES string
[Sm]
InChI
1S/Sm
InChI key
KZUNJOHGWZRPMI-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Water-react 3
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 120(3), 245-255 (2000-03-21)
This review deals with the rapid reduction of a variety of organic functionalities, including a new selective reduction of carboxylic acid, with samarium diiodide in the presence of additives under mild conditions. The single electron donor ability of samarium diiodide
Chemical Society reviews, 33(9), 599-609 (2004-12-14)
The development of methodologies for the formation of carbon-carbon double bonds could be considered one of the most important challenges in organic synthesis. To this end, beta-elimination reactions in 1,2-difunctionalised substrates have been one of the most important means of
Cancer, 88(12 Suppl), 2934-2939 (2000-07-18)
In patients with bone pain due to metastatic disease, intravenous systemic radioisotope therapy may be a useful adjunct to other methods for palliating pain. Various studies have been performed utilizing a short-lived radioisotope conjugated to a tetraphosphonate (samarium 153 lexidronam)
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 123(8), 653-663 (2003-08-23)
Samarium (II) iodide has been employed to promote the vinylogous pinacol coupling reaction of aldehyde to alpha, beta-unsaturated ketones. The diastereoselectivity of 6-endo-trig mode products was changed by the addition of a proton source and/or HMPA and by the reaction
Expert review of anticancer therapy, 7(11), 1517-1527 (2007-11-21)
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153)Samarium lexidronam ((153)Sm-EDTMP; Quadramet, Cytogen) is a radiopharmaceutical designed for deposition into bone metastases. Bone scans can identify patients that
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service